Literature DB >> 10820241

Constitutive expression of a chimeric receptor that delivers IL-2/IL-15 signals allows antigen-independent proliferation of CD8+CD44high but not other T cells.

S Gasser1, P Corthésy, F Beerman, H R MacDonald, M Nabholz.   

Abstract

We have prepared transgenic mice whose T cells constitutively express a chimeric receptor combining extracellular human IL-4R and intracellular IL-2Rbeta segments. This receptor can transmit IL-2/IL-15-like signals in response to human, but not mouse, IL-4. We used these animals to explore to what extent functional IL-2R/IL-15R expression controls the capacity of T cells to proliferate in response to IL-2/IL-15-like signals. After activation with Con A, naive transgenic CD8+ and CD4+ T cells respond to human IL-4 as well as to IL-2. Without prior activation, they failed to proliferate in response to human IL-4, although human IL-4 did prolong their survival. Thus, IL-2-induced proliferation of activated T cells requires at least one other Ag-induced change apart from the induction of a functional IL-2R. However, a fraction of CD8+CD44high T cells proliferate in human IL-4 without antigenic stimulation or syngeneic feeder cells. In contrast, CD4+CD44high T cells are not constitutively responsive to human IL-4. We conclude that although all transgenic T cells express a functional chimeric receptor, only some CD8+CD44high T cells contain all molecules required for entry into the cell cycle in response to human IL-4 or IL-15.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820241     DOI: 10.4049/jimmunol.164.11.5659

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity.

Authors:  SangKon Oh; Jay A Berzofsky; Donald S Burke; Thomas A Waldmann; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

2.  Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4.

Authors:  Scott Wilkie; Sophie E Burbridge; Laura Chiapero-Stanke; Ana C P Pereira; Siobhán Cleary; Sjoukje J C van der Stegen; James F Spicer; David M Davies; John Maher
Journal:  J Biol Chem       Date:  2010-06-18       Impact factor: 5.157

3.  Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells.

Authors:  T A Fehniger; K Suzuki; A Ponnappan; J B VanDeusen; M A Cooper; S M Florea; A G Freud; M L Robinson; J Durbin; M A Caligiuri
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.